| Inhibition of airway inflammation, hyperresponsiveness and remodeling by soy isoflavone in a murine model of allergic asthma. | |
| | |
MedLine Citation:
|
PMID: 21354484 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Epidemiologic studies have associated higher dietary consumption of soy isoflavones with decreased self-report of cough and allergic respiratory symptoms, but the pharmacodynamic effects of soy isoflavone on asthmatic model have not been well-described. Here, we hypothesized that soy isoflavone may have potential effects on airway hyperresponsiveness, inflammation and airway remodeling in a murine of asthma. Mice sensitized and challenged with ovalbumin developed airway inflammation. Bronchoalveolar lavage fluid was assessed for inflammatory cell counts, and for cytokine levels. Lung tissues were examined for cell infiltration, mucus hypersecretion and airway remodeling, and for the expression of inflammatory biomarkers. Airway hyperresponsiveness was monitored by direct airway resistance analysis. Oral administration of soy isoflavone significantly reduced ovalbumin-induced airway hyperresponsiveness to intravenous methacholine, and inhibited ovalbumin-induced increases in eosinophil counts. RT-PCR analysis of whole lung lysates revealed that soy isoflavone markedly suppressed ovalbumin-induced mRNA expression of eotaxin, interleukin(IL)-5, IL-4 and matrix metalloproteinase-9, and increased mRNA expression of interferon (IFN)-γ and tissue inhibitor of metalloproteinase-1 in a dose-dependent manner. Soy isoflavone also substantially recovered IFN-γ/IL-4 (Th1/Th2) levels in bronchoalveolar lavage fluid. In addition, histologic studies showed that soy isoflavone dramatically inhibited ovalbumin-induced lung tissue eosinophil infiltration, airway mucus production and collagen deposition in lung tissues. Our findings suggest that soy isoflavone as nutritional supplement may provide a novel means for the treatment of airway inflammatory disease. |
| | |
Authors:
|
Bao Zhao-Sheng; Hong Ling; Guan Yan; Dong Xin-Wei; Zheng Hua-Sheng; Tan Gong-Li; Xie Qiang-Min |
Related Documents
:
|
140184 - Suppression of immune complex-induced inflammation by the chemotactic factor inactivator. 7499864 - Clearance pathways of soluble immune complexes in the pig. insights into the adaptive n... 7141004 - The leukocyte complement system. 19864604 - Complement activation by cpg in a human whole blood loop system: mechanisms and immunom... 21105164 - Differential monocyte/macrophage interleukin-1β production due to biomaterial topograp... 19765854 - Cannabinoids and experimental models of multiple sclerosis. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-2-24 |
Journal Detail:
|
Title: International immunopharmacology Volume: - ISSN: 1878-1705 ISO Abbreviation: - Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-2-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100965259 Medline TA: Int Immunopharmacol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Elsevier B.V. All rights reserved. |
Affiliation:
|
Taizhou University School of Medicine, Jiaojiang 371000, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.
Next Document: Cytotoxicity and effects on inflammatory response of modified types of cellulose in macrophage-like ...